Martin S. Brown Jr., former Brown-Forman director, joins Cumberland Pharmaceuticals board effective July 15, 2022

CUMBERLAND PHARMACEUTICALS INC

Martin S. Brown Jr., attorney at Adams & Reese LLP, appointed to board effective July 15, 2022.
Brown previously served 10 years on Brown-Forman Corporation's board; has 30 years legal experience.
No arrangements or family relationships with directors or execs; will receive standard non-executive director compensation.
He has not been named to any board committees yet.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Martin S. Brown Jr.

Director

CPIX · CUMBERLAND PHARMACEUTICALS INC

Effective: 2022-07-15
Filed: July 19, 2022, 7:59 PM ET

Effective July 15, 2022, Cumberland Pharmaceuticals Inc. (the "Company") appointed Martin S. Brown Jr, an attorney with Adams & Reese LLP, as the newest member of its Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Martin S. Brown Jr. was appointed as Director at CUMBERLAND PHARMACEUTICALS INC.

Action: appointed
Role: Director

Exact text from the filing

Effective July 15, 2022, Cumberland Pharmaceuticals Inc. (the "Company") appointed Martin S. Brown Jr, an attorney with Adams & Reese LLP, as the newest member of its Board of Directors.

View on SEC.gov

CUMBERLAND PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001628280-22-019114

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.